Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 47

1.

Inclusion of zero total event trials in meta-analyses maintains analytic consistency and incorporates all available data.

Friedrich JO, Adhikari NK, Beyene J.

BMC Med Res Methodol. 2007 Jan 23;7:5.

PMID:
17244367
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Can we individualize the 'number needed to treat'? An empirical study of summary effect measures in meta-analyses.

Furukawa TA, Guyatt GH, Griffith LE.

Int J Epidemiol. 2002 Feb;31(1):72-6.

PMID:
11914297
[PubMed - indexed for MEDLINE]
Free Article
3.

Robustness assessments are needed to reduce bias in meta-analyses that include zero-event randomized trials.

Keus F, Wetterslev J, Gluud C, Gooszen HG, van Laarhoven CJ.

Am J Gastroenterol. 2009 Mar;104(3):546-51. doi: 10.1038/ajg.2008.22.

PMID:
19262513
[PubMed - indexed for MEDLINE]
4.

Effects of adjusting for censoring on meta-analyses of time-to-event outcomes.

Vale CL, Tierney JF, Stewart LA.

Int J Epidemiol. 2002 Feb;31(1):107-11.

PMID:
11914304
[PubMed - indexed for MEDLINE]
Free Article
5.
6.

Meta-analysis of rare events: an update and sensitivity analysis of cardiovascular events in randomized trials of rosiglitazone.

Dahabreh IJ, Economopoulos K.

Clin Trials. 2008;5(2):116-20. doi: 10.1177/1740774508090212. Erratum in: Clin Trials. 2008;5(5):559. Economopoulos, K [added].

PMID:
18375649
[PubMed - indexed for MEDLINE]
7.

Heterogeneity and statistical significance in meta-analysis: an empirical study of 125 meta-analyses.

Engels EA, Schmid CH, Terrin N, Olkin I, Lau J.

Stat Med. 2000 Jul 15;19(13):1707-28. Review.

PMID:
10861773
[PubMed - indexed for MEDLINE]
8.

Robust meta-analytic conclusions mandate the provision of prediction intervals in meta-analysis summaries.

Graham PL, Moran JL.

J Clin Epidemiol. 2012 May;65(5):503-10. doi: 10.1016/j.jclinepi.2011.09.012. Epub 2012 Jan 21.

PMID:
22265586
[PubMed - indexed for MEDLINE]
9.

Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A.

Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. Review.

PMID:
18547499
[PubMed - indexed for MEDLINE]
Free Article
10.

What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data.

Sweeting MJ, Sutton AJ, Lambert PC.

Stat Med. 2004 May 15;23(9):1351-75. Erratum in: Stat Med. 2006 Aug 15;25(15):2700.

PMID:
15116347
[PubMed - indexed for MEDLINE]
11.

Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study.

Nüesch E, Trelle S, Reichenbach S, Rutjes AW, Tschannen B, Altman DG, Egger M, Jüni P.

BMJ. 2010 Jul 16;341:c3515. doi: 10.1136/bmj.c3515.

PMID:
20639294
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Adverse Drug Events Related to Ziprasidone: A Meta-analysis of Randomized, Placebo-Controlled Trials.

Harrington CA, English C.

Pharmacotherapy. 2011 Sep;31(9):840-9. doi: 10.1592/phco.31.9.840.

PMID:
21923584
[PubMed - indexed for MEDLINE]
13.

Comparison of conference abstracts and presentations with full-text articles in the health technology assessments of rapidly evolving technologies.

Dundar Y, Dodd S, Dickson R, Walley T, Haycox A, Williamson PR.

Health Technol Assess. 2006 Feb;10(5):iii-iv, ix-145. Review.

PMID:
16487455
[PubMed - indexed for MEDLINE]
Free Article
14.

Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses.

Hart B, Lundh A, Bero L.

BMJ. 2012 Jan 3;344:d7202. doi: 10.1136/bmj.d7202.

PMID:
22214754
[PubMed - indexed for MEDLINE]
Free Article
15.

Meta-analyses in systematic reviews of randomized controlled trials in perinatal medicine: comparison of fixed and random effects models.

Villar J, Mackey ME, Carroli G, Donner A.

Stat Med. 2001 Dec 15;20(23):3635-47.

PMID:
11746343
[PubMed - indexed for MEDLINE]
16.

Discrepancies between meta-analyses and subsequent large randomized, controlled trials.

LeLorier J, Grégoire G, Benhaddad A, Lapierre J, Derderian F.

N Engl J Med. 1997 Aug 21;337(8):536-42.

PMID:
9262498
[PubMed - indexed for MEDLINE]
Free Article
17.

Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis.

Watanabe N, Omori IM, Nakagawa A, Cipriani A, Barbui C, McGuire H, Churchill R, Furukawa TA; MANGA (Meta-Analysis of New Generation Antidepressants) Study Group.

CNS Drugs. 2010 Jan;24(1):35-53. doi: 10.2165/11319480-000000000-00000. Review.

PMID:
20030418
[PubMed - indexed for MEDLINE]
18.

An empirical study of the effect of the control rate as a predictor of treatment efficacy in meta-analysis of clinical trials.

Schmid CH, Lau J, McIntosh MW, Cappelleri JC.

Stat Med. 1998 Sep 15;17(17):1923-42. Review.

PMID:
9777687
[PubMed - indexed for MEDLINE]
19.

Systematic review on the efficacy of fexofenadine in seasonal allergic rhinitis: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials.

Compalati E, Baena-Cagnani R, Penagos M, Badellino H, Braido F, Gómez RM, Canonica GW, Baena-Cagnani CE.

Int Arch Allergy Immunol. 2011;156(1):1-15. Review.

PMID:
21969990
[PubMed - indexed for MEDLINE]
20.

Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trials.

Vrecer M, Turk S, Drinovec J, Mrhar A.

Int J Clin Pharmacol Ther. 2003 Dec;41(12):567-77.

PMID:
14692706
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk